Scientists at Emory University School of Medicine have identified a new type of anti-inflammatory compound that may be useful in treating a wide range of conditions, including neurodegenerative and ...
LONDON – GenKyoTex SA has raised CHF18 million (US$20.4 million) in a Series C round, enabling it to take the lead product to the point where it is ready to deliver clinical proof of concept for the ...
FRANCE--(BUSINESS WIRE)--Regulatory News: Genkyotex (Paris:GKTX) (Brussels:GKTX) (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and the leader in NOX therapies, today ...
ARCHAMPS, France--(BUSINESS WIRE)--Regulatory News: Genkyotex (Paris:GKTX) (Brussels:GKTX) (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and the leader in NOX therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results